Aprogen’s 20.18 Million Share Rights Offering Causes 85% Dilution for Operating Funds
Aprogen amended its third-party rights offering on June 24, 2026, reducing the new shares from 21 million to 20.18 million. The issue price is set at 1,000 KRW per share, a 60% discount to the current market price of 2,500 KRW. Post-offering, total shares will increase from 23.6 million to about 43.8 million, causing an 85% dilution for existing shareholders.
The raised funds of approximately 20.1 billion KRW will be used entirely for operating capital related to new business initiatives, with no detailed investment plan or return outlook disclosed. Allottees include Dorothy New Technology Fund No.81 and G-Base, the ultimate parent of the largest shareholder.
G-Base reported negative equity of 46 billion KRW and total liabilities of 123.4 billion KRW against assets of 77.4 billion KRW for fiscal 2025, indicating severe financial distress. Dorothy Fund is a single-investor vehicle with limited transparency.
Although the new shares are subject to a one-year lock-up, the steep discount and massive dilution pose a significant negative impact on existing shareholder value.
[AI Summary]Aprogen's third-party rights offering represents extreme dilution, issuing new shares equivalent to 85% of outstanding shares at a 60% discount. The use of proceeds is vaguely defined as operating funds, and one of the counterparties, G-Base, is in a complete capital impairment state, raising serious credit risk. The offering is likely to trigger a sharp stock price decline and substantial loss of value for current shareholders.
KOSPI Filing Information
[Correction of Description] Report on Major Matters (Decision on Paid-in Capital Increase)(Major Management Matters of Subsidiary) (Third-Party Allocation)